Failed Alzheimer's trial does not kill leading theory of disease.
about
Drug candidates in clinical trials for Alzheimer's disease.Divergent synthesis of biflavonoids yields novel inhibitors of the aggregation of amyloid β (1-42).Amyloid-beta immunotherapy: the hope for Alzheimer disease?A Bayesian Model for the Prediction and Early Diagnosis of Alzheimer's Disease.Molecular Mechanisms Underlying Neuroprotective Effect of Intranasal Administration of Human Hsp70 in Mouse Model of Alzheimer's Disease.EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease.Re-imagining Alzheimer's disease - the diminishing importance of amyloid and a glimpse of what lies ahead.Anti-Aβ single-chain variable fragment antibodies restore memory acquisition in a Drosophila model of Alzheimer's diseaseNew Drug Research and Development for Alzheimer's Pathology: Present and Prospect.Lessons from Anti-Amyloid-β Immunotherapies in Alzheimer Disease: Aiming at a Moving Target.Disease modification and Neuroprotection in neurodegenerative disorders.Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.GULP1/CED-6 ameliorates amyloid-β toxicity in a Drosophila model of Alzheimer's disease.Restoring synaptic plasticity and memory in mouse models of Alzheimer's disease by PKR inhibition.(-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease.The molecular basis of Alzheimer's plaques.Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease.Dysregulated Metabolism of the Amyloid-β Protein and Therapeutic Approaches in Alzheimer Disease.Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse".Anticoagulants inhibit proteolytic clearance of plasma amyloid beta.Recent insights into the cellular and molecular determinants of aging.The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.Towards an Integrative Understanding of tRNA Aminoacylation-Diet-Host-Gut Microbiome Interactions in Neurodegeneration.Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activatorPhosphorylation of the Amyloid-Beta Peptide Inhibits Zinc-Dependent Aggregation, Prevents Na,K-ATPase Inhibition, and Reduces Cerebral Plaque DepositionComputational Analysis for the Rational Design of Anti-Amyloid Beta (Aβ) Antibodies
P2860
Q33916749-A3696766-1A51-4645-97AD-6E5C5A66E7FBQ36373920-2C8BFA98-25C2-44DC-8630-7A30DDC787F6Q37679265-E30D6619-B53D-402E-A814-90E87C3EA4A8Q37731885-9C6D2E26-73DD-40F5-8ED1-4F5FAEFAF2A3Q38651368-9762A7B2-FC48-4787-9B7C-6931AAF6230BQ38733357-D25A0DDE-6307-41CF-89D8-BDAFD7B563AFQ39332179-7B7F032D-B8A4-495A-8873-05DB333F8CB7Q41199012-AE2298C5-BCA7-4E98-87F2-20DC3E8D07ABQ41687312-C2398CCD-E7CA-41CE-A79D-DBC9AA6AA97EQ42007256-E631203D-03E1-4F93-A295-2DB82FDD8565Q42363882-279F1BD2-1546-4E8D-BE43-50DAE452EBA9Q46240783-99A5873B-8539-4236-B7CA-7C2F184BDDFFQ47096771-71A2FA52-335F-4B43-91A2-4567A4A19679Q47163345-E78C434C-FD6F-4C49-AE19-71D93C218AE4Q47659665-3E29376B-79AB-4C5B-AA07-E709909C6E64Q47689801-3051F8A4-86DB-4E75-871E-DB72FD121AA7Q47743028-ABEE5B38-A210-4608-995D-A5015CD86F01Q48113034-D47C6374-24D8-4E40-B3AC-A3B7978557D9Q48165579-869F2AD9-5C04-44BA-B1E0-97504ABC1F08Q48762558-BD41B4C3-DC5C-4788-91ED-8891C5237031Q49787919-EF4D2EF7-FF3C-4EE6-97E5-470B34A216ADQ50115780-4A27454B-4BC0-42CB-BBE4-CC527FB9B9BBQ54977832-7363E5D2-4BD9-4EA1-BB62-EA71D1A236E7Q55003935-970C575F-E64C-4477-B9AF-758F018E0A59Q57054631-04DCB5A3-8616-4E0B-92A3-0810C80A31C5Q57721645-9637D906-668F-4C85-A120-7D9A88D99E66Q57903229-FCD37A87-BB06-4EDE-ABFC-6CA2046E03C3
P2860
Failed Alzheimer's trial does not kill leading theory of disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Failed Alzheimer's trial does not kill leading theory of disease.
@en
Failed Alzheimer's trial does not kill leading theory of disease.
@nl
type
label
Failed Alzheimer's trial does not kill leading theory of disease.
@en
Failed Alzheimer's trial does not kill leading theory of disease.
@nl
prefLabel
Failed Alzheimer's trial does not kill leading theory of disease.
@en
Failed Alzheimer's trial does not kill leading theory of disease.
@nl
P1433
P1476
Failed Alzheimer's trial does not kill leading theory of disease.
@en
P2888
P356
10.1038/NATURE.2016.21045
P407
P577
2016-11-01T00:00:00Z
P6179
1023866934